Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 213 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05139017
- Conditions
- DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) Glendale, Arizona, United States
- Beverly Hills Cancer Center ( Site 0184) Beverly Hills, California, United States
- Bass Medical Group ( Site 0166) Walnut Creek, California, United States
- Innovative Clinical Research Institute ( Site 0122) Whittier, California, United States
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- USA Mitchell Cancer Institute ( Site 0173) Mobile, Alabama, United States
- Banner MD Anderson Cancer Center ( Site 0165) Gilbert, Arizona, United States
- Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0167) Phoenix, Arizona, United States
- The University of Arizona Cancer Center - North Campus ( Site 0124) Tucson, Arizona, United States
NCT03223610
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +17 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06395103
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +32 more
- Locations
-
- Children's Hospital Los Angeles ( Site 1006) Los Angeles, California, United States
- Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016) Aurora, Colorado, United States
- Yale New Haven Hospital ( Site 1012) New Haven, Connecticut, United States
- Johns Hopkins All Children's Hospital ( Site 1025) St. Petersburg, Florida, United States
Recruiting
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
NCT04002947
- Conditions
- DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06863402
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +20 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT06249191
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +10 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT01804686
- Conditions
- Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +43 more
- Locations
-
- City of Hope Cancer Center Duarte, California, United States
- University of California San Diego Medical Center La Jolla, California, United States
- University of California Los Angeles Los Angeles, California, United States
- St. Joseph Hospital Center for Cancer Prevention and Treatment Orange, California, United States
NCT03501576
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +25 more
- Locations
-
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT07200375
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences. Langfang, Hebei, China
- Chinese Academy of Medical Sciences Hematology Hospital;Lymphoma Diagnosis and Treatment Center Tianjin, Tianjin Municipality, China
- Peking University People's Hospital Beijing, China
- Peking University Third Hospital Beijing, China
NCT06929624
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT05954910
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Peking Union Medical College Hospital Beijing, China
- Peking University Third Hospital Beijing, China
- Beijing Hospital of Ministry of Health Beijing, China
- Beijing Tongren Hospital, Capital Medical University Beijing, China
Recruiting
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
NCT05952024
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Research Site Berkeley, California, United States
- Research Site La Jolla, California, United States
- Research Site Orange, California, United States
- Research Site Stamford, Connecticut, United States
NCT04094311
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
- Locations
-
- Novartis Investigative Site Hamilton, Ontario, Canada
- Novartis Investigative Site Ottawa, Ontario, Canada
- Novartis Investigative Site Toronto, Ontario, Canada
- Novartis Investigative Site Toronto, Ontario, Canada
NCT06898905
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Yale University New Haven, Connecticut, United States
NCT06977711
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University Hospital System San Antonio, Texas, United States
- University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center San Antonio, Texas, United States
Recruiting
Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission
NCT07507318
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT04844866
- Conditions
- Diffuse Large B-cell Lymphoma, Hematologic Diseases, Hematologic Neoplasms, +12 more
- Locations
-
- LKH - Medizinische Universitaet Graz Graz, Austria
- Universitatsklinikum Innsbruck Universitatsklinik fur Innere Medizin V Innsbruck, Austria
- Ordensklinikum Linz GmbH Elisabethinen Linz, Austria
- Medizinische Universitaet Wien - Allgemeines Krankenhaus der Stadt Wien (AKH) Vienna, Austria
NCT06594640
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Institute of Hematology & Blood Disease Hospital Tianjin, Tianjin Municipality, China
Recruiting
R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse
NCT05257018
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Dongmei Ji Shanghai, Shanghai Municipality, China
- Cancer Hospital affilicaited to Xinjiang Medical University Ürümqi, Xinjiang, China